The role of somatostatin and its analogs in the diagnosis and treatment of tumors - PubMed (original) (raw)

Review

The role of somatostatin and its analogs in the diagnosis and treatment of tumors

S W Lamberts et al. Endocr Rev. 1991 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Evaluation of receptors for somatostatin in various tumors using different analogs.
  Srkalovic G, Cai RZ, Schally AV. Srkalovic G, et al. J Clin Endocrinol Metab. 1990 Mar;70(3):661-9. doi: 10.1210/jcem-70-3-661. J Clin Endocrinol Metab. 1990. PMID: 1968467
• Absence of somatostatin receptors in psoriatic skin lesions.
  Reubi JC, Hunziker T. Reubi JC, et al. Arch Dermatol Res. 1990;282(2):139-41. doi: 10.1007/BF00493474. Arch Dermatol Res. 1990. PMID: 1972322 No abstract available.
• [Nerve tissue distribution and physiologic role of somatostatin and its receptor].
  Shimizu N, Tanaka K, Ito S. Shimizu N, et al. Nihon Rinsho. 1990 May;48(5):1037-41. Nihon Rinsho. 1990. PMID: 1973950 Japanese. No abstract available.
• The role of somatostatin analogs in the control of tumor growth.
  Lamberts SW, Reubi JC, Krenning EP. Lamberts SW, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):61-4. Semin Oncol. 1994. PMID: 7992085 Review. No abstract available.
• [Somatostatin, somatostatin analogs and their clinical use].
  Krsek M. Krsek M. Cas Lek Cesk. 2003 Mar;142(3):134-8; discussion 139. Cas Lek Cesk. 2003. PMID: 12756839 Review. Czech.

Cited by

• Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias.
  Periferakis A, Tsigas G, Periferakis AT, Tone CM, Hemes DA, Periferakis K, Troumpata L, Badarau IA, Scheau C, Caruntu A, Savulescu-Fiedler I, Caruntu C, Scheau AE. Periferakis A, et al. Curr Issues Mol Biol. 2024 Sep 2;46(9):9721-9759. doi: 10.3390/cimb46090578. Curr Issues Mol Biol. 2024. PMID: 39329930 Free PMC article. Review.
• Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists.
  Li J, You C, Li Y, Li C, Fan W, Chen Z, Hu W, Wu K, Xu HE, Zhao LH. Li J, et al. Proc Natl Acad Sci U S A. 2024 Jun 25;121(26):e2321710121. doi: 10.1073/pnas.2321710121. Epub 2024 Jun 17. Proc Natl Acad Sci U S A. 2024. PMID: 38885377
• Somatostatin and Somatostatin Receptors in Tumour Biology.
  Kumar U. Kumar U. Int J Mol Sci. 2023 Dec 28;25(1):436. doi: 10.3390/ijms25010436. Int J Mol Sci. 2023. PMID: 38203605 Free PMC article. Review.
• Identification and Management of Aggressive Meningiomas.
  Patel B, Desai R, Pugazenthi S, Butt OH, Huang J, Kim AH. Patel B, et al. Front Oncol. 2022 Mar 23;12:851758. doi: 10.3389/fonc.2022.851758. eCollection 2022. Front Oncol. 2022. PMID: 35402234 Free PMC article. Review.
• Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.
  Behling F, Fodi C, Skardelly M, Renovanz M, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J. Behling F, et al. Neurosurg Rev. 2022 Feb;45(1):467-478. doi: 10.1007/s10143-021-01552-y. Epub 2021 Apr 26. Neurosurg Rev. 2022. PMID: 33899156 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database